Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
PaperCitations, authors & open-access status
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 231 citations, 2021 year and closed oa status.
231
Citations
2021
Year
closed
OA Status